Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-21

Clinical Trial Update: Restylane Perlane Lidocaine for Correction of Midface Volume Deficit and/or Midface Contour Deficiency [NA]

View source ↗

Summary

Clinical trial update for Restylane Perlane Lidocaine in correcting midface volume deficit and/or midface contour deficiency has completed; results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Restylane Perlane Lidocaine (restylane perlane lidocaine)

Snippet

Sponsor: Galderma R&D | Conditions: Midface Volume Deficit | NA | Status: COMPLETED | Results posted: 2021-07-21